Aspirin Link To Pancreatic Cancer Risk In Study “Inconclusive” – Bayer
This article was originally published in The Tan Sheet
Results of a newly published study indicating that women who use aspirin two or more times per week are at an increased risk of pancreatic cancer are not "conclusive," Bayer Consumer Care maintains
You may also be interested in...
"Extended aspirin use may be associated with significantly increased cancer risk among women," Eva Schernhammer, MD, Harvard University Medical School, et al., reported at a meeting of the American Association for Cancer Research in Phoenix Oct. 26-30. Among 88,378 participants in the Nurses' Health Study, researchers identified 161 cases of pancreatic cancer in previously cancer-free individuals. The risk increased 58% for women who took aspirin twice a week or more for more than 20 years. "These findings, if confirmed, add another variable to the complex risk-benefit profile of aspirin," Schernhammer cautioned...
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning